Reginald L. Hardy

Reginald L. Hardy, listed as chief executive, appears in our data through filings on Fresh Tracks Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 14 February 2020 to 31 December 2021, the count stands at 24 filings.

The open-market record is one-sided, with 2 purchases worth €113k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 14 share grants and 8 option exercises.

Most recently, on 25 February 2022, the filings show a share grant worth €3,068 in Fresh Tracks Therapeutics, Inc. The latest purchase dates back some time: it was published 1,931 days ago, on 27 July 2021. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.